Information Provided By: 
Fly News Breaks for March 4, 2019
AXP
Mar 4, 2019 | 08:38 EDT
Ahead of American Express' investor day meeting, Stephens analyst Vincent Caintic said he believes the event is likely to be a positive catalyst for the shares, noting that he expects the company's currently wide range for FY19 EPS growth to be tightened toward the high-end. Global Consumer Services has been driving the overall story, said Caintic, who expects the company to talk about the opportunities in Commercial and Network. He maintains an Overweight rating and $131 price target on American Express shares ahead of the March 13 investor event.
News For AXP From the Last 2 Days
AXP
Apr 22, 2024 | 09:05 EDT
BMO Capital raised the firm's price target on American Express to $175 from $167 and keeps an Underperform rating on the shares. The firm cites the company's broad-based Q1 earnings beat, with higher than previously-modeled net interest income and slightly lower credit costs being partly offset by higher expected operating expenses. BMO adds however that it remains concerned that American Express's elevated loan restructuring rate could eventually bleed into higher credit provisions.
AXP
Apr 22, 2024 | 09:01 EDT
AXP
Apr 22, 2024 | 08:13 EDT
RBC Capital raised the firm's price target on American Express to $253 from $250 and keeps an Outperform rating on the shares. The company's Q1 results showed a "good quarter" with revenues that met expectations, controlled core expenses, and acceptable credit trends, the analyst tells investors in a research note. While spend volumes continued to moderate, American Express management remains confident on the near and longer term revenue trajectory, the firm added.
AXP
Apr 22, 2024 | 08:10 EDT
Morgan Stanley raised the firm's price target on American Express to $226 from $222 and keeps an Equal Weight rating on the shares following Q1 results that were better than expected, led by net interest income, credit, and expenses. The firm is taking forward EPS up 1%, noting that its 2024 estimate is now above the midpoint of management's EPS guidance at $13.02, though it maintains an Equal Weight rating, citing valuation.
